483
Paul W. Wallace, MDPaul W. Wallace, MD – FDA 483, Mar 17, 2026
Record Details
An FDA inspection of Paul W. Wallace, MD in Los Angeles, CA, revealed significant deviations from investigational plans. The firm failed to complete numerous required procedures and assessments for multiple subjects across two protocols. Additionally, a large number of enrolled subjects missed all study visits due to personnel changes, indicating a severe lack of adherence to clinical trial protocols.
View Company Profile
ID · 6412ed93-d955-4c0b-a44c-e8cf3b5a5cfa
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.